Actelion's efforts in drug discovery have focused on developing platforms of expertise based on its core capabilities. This focus allows high productivity in the generation of innovative compounds potentially addressing a wide range of highly unmet medical needs.

The mechanism of action gives information about how our innovative compounds affect specific biological processes on a living organism or a biochemical system.